Cardiovascular & Thoracic Surgery News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor recurrence. History has proven that an incentive for a repeat surgery is there. A recent 30-year retrospective review at Wake Forest Baptist Medical Center has shown how beneficial the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, or HIPEC, can be for several cancers with peritoneal metastasis. “People often think it’s a one-and-done procedure,” Wake Forest Baptist surgical oncologist Dr. Edward Levine told The M...
Source: Asbestos and Mesothelioma News - April 13, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

Who Gets Heart Benefits From Bariatric Surgery? Study Casts a Wider Net
(MedPage Today) -- The case for bariatric surgery's cardiovascular benefits was bolstered by a large nationwide cohort study of older people. Major adverse cardiovascular events were significantly reduced among 94,885 Medicare patients who received... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 11, 2022 Category: Cardiology Source Type: news

The Connection Between IBD and Aging
Inflammatory bowel disease (IBD) has long been thought of as an ailment of middle, or even young, adulthood. The chronic illness—which includes Crohn’s disease and ulcerative colitis, and can cause abdominal pain, diarrhea, bleeding, and decreased quality of life—impacts about 3.1 million people in the U.S. However, it is far from a disease only of the young and middle-aged. More than a quarter of people with IBD are elderly, a figure that is projected to climb to 30% by 2030, according to a 2021 Gastroenterology & Hepatology article. Even more underappreciated is the growing population of people who ...
Source: TIME: Health - April 8, 2022 Category: Consumer Health News Authors: Katherine Harmon Courage Tags: Uncategorized Disease healthscienceclimate Source Type: news

ACC: Bleeding Risk Lower With Tranexamic Acid in Noncardiac Surgery
THURSDAY, April 7, 2022 -- For patients undergoing noncardiac surgery, the incidence of a composite bleeding outcome is significantly lower with tranexamic acid, while tranexamic acid is not noninferior for the composite cardiovascular outcome,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 7, 2022 Category: Pharmaceuticals Source Type: news

Tranexamic Acid Cuts Surgical Bleeding in Yet Another Setting
(MedPage Today) -- A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The antifibrinolytic drug cut life-threatening... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 2, 2022 Category: Surgery Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)
TITUSVILLE, N.J., March 31, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted by PAD.1 Janssen has joined forces with leading professional associations, healthcare systems and community organizations to advance equitable care for individuals and communities placed at an...
Source: Johnson and Johnson - March 31, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Are Potential Physical Examination Findings for Patients with Atrioventricular Canal Defects?
Discussion Atrioventricular canal defects (AVCD) are a heterogeneous range of congenital heart defects (CHD) arising from malformations of intracardiac septal development. Essentially the location where the 4 corners of the 2 atria and 2 ventricula meet is abnormally formed. There is partial or complete fusion of the mitral and tricuspid valves along with atrial (ASD) and ventricular septal defects (VSD). Fusion of the endocardial cushions occurs around 4-5 weeks gestation. The anatomy for an individual is bespoke as the variations of the valve leaflets, chordal attachments and variations in ASD and VSD are numerous. This ...
Source: PediatricEducation.org - March 21, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Thoracic splenosis mimicking pleural tumor after firearm injury: a case report with long-term follow-up - S önmez, Kılıç B, Turna A.
Splenosis describe a clinical entity of autotransplantation after removal of the spleen secon-dary to a traumatic rupture or surgery. A 39-year-old female was referred to thoracic surgery department with complaints of severe chest pain. She had left thorac... (Source: SafetyLit)
Source: SafetyLit - February 6, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Guidelines Address Management of Type B Aortic Dissection
THURSDAY, Feb. 3, 2022 -- In clinical practice guidelines issued by the Society of Thoracic Surgeons and American Association for Thoracic Surgery and published online Jan. 25 in the Annals of Thoracic Surgery and the Journal of Thoracic and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2022 Category: Pharmaceuticals Source Type: news

NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma. It is a long-awaited, much-needed breakthrough. The potential intraoperative adjuvant is a spray-on hydrogel involving genetically engineered molecular nanoparticles designed to specifically target and kill tumor cells. It showed surprising efficacy in a recent laboratory study at the NCI with mesothelioma models in mice. Nature Nanotechnology published the study, detailing the impressive results. “This could be a huge deal, potentially a real game-changer in treating ...
Source: Asbestos and Mesothelioma News - February 1, 2022 Category: Environmental Health Authors: Fran Mannino Source Type: news

Mesothelioma Specialty Centers Factor in 2021 Best Hospital Rankings
University of Texas MD Anderson Cancer Center in Houston is No. 1 for the seventh consecutive year on the prestigious U.S. News & World Report Best Hospitals for Cancer list. The annual cancer rankings were included in the media company’s recently published Best Hospitals 2022 guidebook. Cancer is one of the 15 specialties for which hospitals in the U.S. were ranked. Other hospitals in the top five are: Memorial Sloan Kettering Cancer Center in New York City; Mayo Clinic in Rochester, Minnesota; Dana-Farber/Brigham and Women’s Hospital in Boston and the Cleveland Clinic Cancer Center. Mesothelioma specialt...
Source: Asbestos and Mesothelioma News - January 12, 2022 Category: Environmental Health Authors: James Fannon Source Type: news

Heart Surgery Patients May Not Need Opioids at Home
MONDAY, Dec. 27, 2021 -- Cardiac surgery patients can manage postoperative pain with nonopioid pain medications at home, according to a study published online Dec. 15 in The Annals of Thoracic Surgery. Catherine M. Wagner, M.D., from University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease who have...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How Much Weight Should be Used in Strength Training?
Discussion The benefits of strength training includes improved performance, injury prevention and rehabilitation, improved cardiovascular fitness, improved bone mineral density, improved blood lipid profiles and mental health. The most common risk is injury and most of these “…occur on home equipment with unsafe behavior and unsupervised settings.” Children with a variety of health problems should be evaluated first including hypertension, congenital heart disease, previous use of cardiotoxic medication, seizures, obesity, and Marfan syndrome. Other counseling issues regarding strength training include di...
Source: PediatricEducation.org - December 20, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news